Upcoming event

Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC)

2022-02-19

Dr. Grivas (US) elaborates on his study “Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC)” which he presented at ASCO GU22.

Tags: ASCO GU22